Materiali per i gruppi di lavoro:

Slide Kit 2009

Guida 2009

Gold Report 2009

Videoconferenze:

Videoconferenza 13 Gennaio 2010 - parte I

Videoconferenza 13 Gennaio 2010 - parte II

Chat Videoconferenza 13 Gennaio 2010

Videoconferenza 15 Febbraio 2010 - parte I

Videoconferenza 15 Febbraio 2010 - parte II

Videoconferenza 15 Febbraio 2010 - parte III

Proposta gruppi di lavoro:

Chairman: L. Corbetta

Definizione ed aspetti sistemici
R. Antonelli Incalzi, C. Nozzoli, P. Roversi, L.M. Fabbri
Materiale:
• Definizione-aspetti sistemici 2010
Classificazione di gravità
P. Palange,  B. Balbi, T. Benedetti, R. Maselli

Epidemiologia e costi della BPCO
R. De Marco, R. Pistelli, R. Dal Negro, L.Carrozzi. G. Viegi

C. Mapp, M. Luisetti, M. Sofia

• The COPD genetic association compendium: a comprehensive online database of COPD genetic associations
• Chronic obstructive pulmonary disease in non-smokers
• Fattori di rischio : Messaggi principali
• Laboratory diagnosis of alpha₁-antitrypsin deficiency
• Diagnosi_AATD_Gold_2010
• fattori di rischio bpco 2010

Anatomia patologica e patogenesi
 M. Saetta, S. Baraldo, G. Caramori, M. Cosio, A. Sanduzzi, A. Zanini

• Elenco articoli

Screening ed inquadramento diagnostico
P. Maestrelli, A. Rossi
Materiale:
• Percent Emphysema, Airflow Obstruction, and Impaired Left Ventricular Filling
• Classifying the severity of COPD: are the new severity scales better than the old?
• THE RATIO OF FORCED EXPIRATORY VOLUME IN 1-SECOND TO FORCED VITAL CAPACITY AS A BASIS FOR ESTABLISHING CHRONIC OBSTRUCTIVE PULMONARY DISEASE
• Defining chronic obstructive pulmonary disease in older persons
• Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study
• Modena-GOLD2010
Imaging e caratterizzazione fenotipica
M. Pistolesi, M. Zompatori, M. Maffesanti

Azioni contro il fumo di sigaretta ed altre azioni preventive
L.Carrozzi, E. Sabato, S. Nutini, R. Polosa

• Gold 2010 proposte
• GOLD 2010 Nutini
• Smoking Cessation - Chest 2010

• Cardiovascular Safety of Tiotropium in Patients With COPD
• Anticholinergic Drugs for the Treatment of COPD Are Safe...Are They?
• ERS-ATS COPD Guidelines
• Efficacy and Tolerability of Budesonide/Formoterol Added to Tiotropium in Patients with Chronic Obstructive Pulmonary Disease
• La scomparsa dello stadio 0 della BPCO nelle Linee Guida GOLD 2006
• Chronic Obstructive Pulmonary Disease: Management of adults 8 with chronic obstructive pulmonary disease in primary and 9 secondary care
• Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study
• COPD recommendations - 2008 Primary care update
• BPCO terapia 2009
• Proposte LG GOLD Italia 2010
• Mortality in the 4-Year Trial of Tiotropium (UPLIFT) in Patients with Chronic Obstructive Pulmonary Disease
• Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecifi ed subgroup analysis of a randomised controlled trial
• RCP Spiriva dicembre 2009
• Meeting the Obligation to Balance Bioethics and Clinical Trial Design in Asthma
• Update in Chronic Obstructive Pulmonary Disease 2009
• Genetics, Ethics, and the Use of Long-acting β-Adrenergics to Treat Asthma

• Development and first validation of the COPD Assessment Test
• Development and first validation of the COPD Assessment Test
• Proposte LG GOLD Italia 2010

• LG Mod 2010 Biomarkers
• LG Mod 2010 Biomarkers1
• LG Mod 2010 Biomarkers2
• LG Mod 2010 Biomarkers3

Diagnosi e gestione clinica delle riacutizzazioni
A. Spanevello, S. Calabro, ML. Bocchino (Na), F Blasi

• Domande e risposte sul ritiro della domanda di autorizzazione all’immissione in commercio per Factive gemifloxacin

Trattamento intensivo respiratorio
A. Corrado, N. Ambrosino, F. Sgambato, S. Nava

G. Bettoncelli, L, Corbetta, G. Carnesalli, P. Spriano,M.Calzolai, F.Chiumeo, Manfredi, R. Testi, N. Seminara, L.Langella, F. Lombardo, A Naddeo, I. Paolini,     A. Bussotti, G Virgili

• yrmed_3067
• Art SIMG Bozza

L. Corbetta, P. Vivoli, B. Rusticali

F. Luppi, B. Beghè, L. Corbetta

• Indacaterolo
• GOLD 2010 - New treatments in COPD
• Emerging Pharmacotherapies for COPD
• Integrating indacaterol dose selection in a clinical study in COPD using an adaptive seamless design
• Bronchodilator effects of indacaterol and formoterol in patients with COPD
• Rofl umilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials
• Rofl umilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials
• The Safety and Efficacy of Infliximab in Moderate to Severe Chronic Obstructive Pulmonary Disease
• First Study of Infliximab Treatment in Patients with Chronic Obstructive Pulmonary Disease
• Indacaterol, a Novel Inhaled, Once-Daily, Long-Acting Beta2-Agonist for the Treatment of Obstructive Airways Diseases
• Nuovi trattamenti per la BPCO